The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tanguler Tolga since 2022.
This trader's CIK number is 1849458.
At the time of last reporting, Tanguler Tolga was the EVP, Chief Commercial Officer of Alnylam Pharmaceuticals, Inc.. (stock ticker symbol ALNY).
Also see all insider trading activities at Alnylam Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALNY | 0 | $0 | 5,854 | $2,430,103 | 1,667 | $0 |
| 2024 | ALNY | 0 | $0 | 4,584 | $963,904 | 1,667 | $0 |
| 2023 | ALNY | 0 | $0 | 6,501 | $1,440,480 | 5,025 | $0 |
| 2022 | ALNY | 0 | $0 | 5,349 | $1,035,813 | 5,026 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-29 | ALNY | Sale | 3,474 | 449.02 | 1,559,888 |
| 2025-08-18 | ALNY | Sale | 1,396 | 452.31 | 631,423 |
| 2025-03-03 | ALNY | Sale | 471 | 244.82 | 115,311 |
| 2025-02-28 | ALNY | Sale | 513 | 240.70 | 123,481 |
| 2025-02-27 | ALNY | Option Ex | 1,667 | .00 | 0 |
| 2024-11-26 | ALNY | Sale | 1,469 | 250.35 | 367,761 |
| 2024-06-25 | ALNY | Sale | 1,605 | 229.42 | 368,220 |
| 2024-02-27 | ALNY | Option Ex | 1,667 | .00 | 0 |
| 2024-02-28 | ALNY | Sale | 501 | 156.35 | 78,332 |
| 2024-02-16 | ALNY | Sale | 1,009 | 148.26 | 149,591 |
| 2023-04-27 | ALNY | Sale | 1,476 | 194.96 | 287,755 |
| 2023-02-01 | ALNY | Option Ex | 5,025 | .00 | 0 |
| 2023-02-02 | ALNY | Sale | 1,601 | 225.94 | 361,734 |
| 2023-02-03 | ALNY | Sale | 3,424 | 231.01 | 790,991 |
| 2022-08-03 | ALNY | Sale | 1,754 | 210.00 | 368,340 |
| 2022-08-05 | ALNY | Sale | 1,841 | 219.65 | 404,373 |
| 2022-07-05 | ALNY | Sale | 1,754 | 150.00 | 263,100 |
| 2022-02-01 | ALNY | Option Ex | 5,026 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tanguler Tolga (EVP, Chief Commercial Officer of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.